[
  {
    "objectID": "exercises.html",
    "href": "exercises.html",
    "title": "Getting there: Exercises",
    "section": "",
    "text": "Recommended: Complete these exercises in the dedicated R in Pharma RStudio Cloud work space, which comes with\n\nall packages pre-installed, and\nan Rmarkdown document to fill in.\n\nIt may still be helpful to peek here to verify that your tables match the desired output.\nClick here to enter R in Pharma RStudio Cloud work space for our workshop\nOtherwise: Follow along this document, work on your personal computer, and challenge yourself not to peek at the code solutions until you have completed the exercise."
  },
  {
    "objectID": "exercises.html#exercise-4---kaplan-meier-plot",
    "href": "exercises.html#exercise-4---kaplan-meier-plot",
    "title": "Getting there: Exercises",
    "section": "Exercise 4 - Kaplan-Meier plot",
    "text": "Exercise 4 - Kaplan-Meier plot\nLets try now to create an efficacy Kaplan-Meier plot.\nKMG01"
  },
  {
    "objectID": "exercises.html#exercise-5---try-teal.gallery",
    "href": "exercises.html#exercise-5---try-teal.gallery",
    "title": "Getting there: Exercises",
    "section": "Exercise 5 - Try {teal.gallery}",
    "text": "Exercise 5 - Try {teal.gallery}\nteal.gallery"
  },
  {
    "objectID": "feedback.html",
    "href": "feedback.html",
    "title": "Feedback",
    "section": "",
    "text": "Click here to enter the feedback form."
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "",
    "text": "üóì October 28, 2024 | 9:00am - 12:30pm EDT\nüè® Virtual\nüí• FREE workshop registration"
  },
  {
    "objectID": "index.html#learning-objectives",
    "href": "index.html#learning-objectives",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Learning objectives",
    "text": "Learning objectives\nAfter a vision-filled motivational introduction, and through a succession of practical examples, this session will empower R developers, data scientists, and clinical researchers to adopt innovative, future-ready approaches."
  },
  {
    "objectID": "index.html#is-this-course-for-me",
    "href": "index.html#is-this-course-for-me",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Is this course for me?",
    "text": "Is this course for me?\nEver wondered how clinical trials reporting may look in the future? Are you interested in learning about some of the latest tools and technologies transforming regulatory submissions? Do you want to explore the potential of R in clinical research? If you answered yes to any of these questions, this workshop is for you!\nThe workshop is not designed only for those who are masters in R. We will bring you along an intuitive path to produce reproducible (and interactive) reports."
  },
  {
    "objectID": "index.html#prework",
    "href": "index.html#prework",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Prework",
    "text": "Prework\nBefore attending the workshop please check our posit cloud work space and create your own assignment. All packages needed are already installed there (it is a clone of the exercise folder)."
  },
  {
    "objectID": "index.html#additional-resources",
    "href": "index.html#additional-resources",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Additional resources",
    "text": "Additional resources"
  },
  {
    "objectID": "license.html",
    "href": "license.html",
    "title": "License",
    "section": "",
    "text": "This material is based on the original work from the {gtreg} workshop by Shannon Pileggi and Daniel Sjoberg, available here, and adapted under a Creative Commons Attribution 4.0 International License."
  },
  {
    "objectID": "slides/index.html#licensing",
    "href": "slides/index.html#licensing",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Licensing",
    "text": "Licensing\n\nThis material is based on the original work from the {gtreg} workshop by Shannon Pileggi and Daniel Sjoberg, available here, and adapted under a Creative Commons Attribution 4.0 International License."
  },
  {
    "objectID": "slides/index.html#instructors",
    "href": "slides/index.html#instructors",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Instructors",
    "text": "Instructors\n\n\nDavide Garolini\n\n\n @melkiades\n melkiades\n davidegarolini\n\nLeena Khatri\n\n khatril\n leena-khatri-a8a364108"
  },
  {
    "objectID": "slides/index.html#schedule",
    "href": "slides/index.html#schedule",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Schedule",
    "text": "Schedule\n\n\n\nTime\nActivity\n\n\n\n\n09:00 - 09:20\nWhy Change?\n\n\n09:20 - 10:10\nGetting there (P1)\n\n\n10:10 - 10:20\nBreak\n\n\n10:20 - 11:10\nGetting there (P2)\n\n\n11:10 - 11:20\nWhat do we expect?\n\n\n11:20 - 11:30\nAdditional resources: Collaborate!\n\n\n\n\nPlease add any questions to the public Zoom chat. These may be answered in the moment or addressed at the end depending on context."
  },
  {
    "objectID": "slides/index.html#main-task-reporting-clinical-trials",
    "href": "slides/index.html#main-task-reporting-clinical-trials",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Main task: reporting clinical trials",
    "text": "Main task: reporting clinical trials\n  \nPurpose of regulatory submissions is to show efficacy and safety of new drugs.\n\n\n\nDeliver analysis reports, datasets, and software\nHealth Authorities (HA) need to be able to reproduce key results"
  },
  {
    "objectID": "slides/index.html#why-migrate-to-r-in-clinical-trials",
    "href": "slides/index.html#why-migrate-to-r-in-clinical-trials",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Why migrate to R in Clinical Trials?",
    "text": "Why migrate to R in Clinical Trials?\nBenefits for all\n \n\n\nCost Efficiency: R is free, reducing software costs.\nFlexibility: R offers greater customization and a vast package ecosystem.\nCommunity Support and Collaboration: R has a large, active community driving rapid innovation."
  },
  {
    "objectID": "slides/index.html#section",
    "href": "slides/index.html#section",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "",
    "text": "From R/Adoption Series: R and Shiny in Regulatory Submissions"
  },
  {
    "objectID": "slides/index.html#section-1",
    "href": "slides/index.html#section-1",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "",
    "text": "From R/Adoption Series: R and Shiny in Regulatory Submissions"
  },
  {
    "objectID": "slides/index.html#section-2",
    "href": "slides/index.html#section-2",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "",
    "text": "From https://pharmaverse.org/"
  },
  {
    "objectID": "slides/index.html#why-migrating-to-r-in-clinical-trials",
    "href": "slides/index.html#why-migrating-to-r-in-clinical-trials",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Why migrating to R in Clinical Trials?",
    "text": "Why migrating to R in Clinical Trials?\nWhat‚Äôs in it for us\n\n\n\nTalent Pool: Growing number of professionals trained in R.\nTransparency: R‚Äôs open-source nature ensures full transparency and reproducibility.\nIntegration: R easily integrates with modern data tools and platforms.\nR is a transversal skill: other business units may benefit from R programmers.\nScalability in complexity: very novel methods can be readily applied to clinical trials growing in complexity."
  },
  {
    "objectID": "slides/index.html#roche---pioneering-modernised-solutions-in-r",
    "href": "slides/index.html#roche---pioneering-modernised-solutions-in-r",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Roche - Pioneering modernised solutions in R",
    "text": "Roche - Pioneering modernised solutions in R\n \n\n2017 ¬†¬†‚Üí PoCs\n{rtables}, {teal} for interactive work were launched and presented at RinPharma\n\n\n\n2021 ¬†¬†‚Üí Open-source\n{rtables} made the first CRAN release, followed by open source of the codebase to kick off collaborations with other companies"
  },
  {
    "objectID": "slides/index.html#roche---pioneering-modernised-solutions-in-r-1",
    "href": "slides/index.html#roche---pioneering-modernised-solutions-in-r-1",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Roche - Pioneering modernised solutions in R",
    "text": "Roche - Pioneering modernised solutions in R\n \n\n2023 ¬†¬†‚Üí Adoption of tools and systems\nValidated environment to deliver our vision of R in submissions\n\n\n\n2024 ¬†¬†‚Üí E2E submission in R"
  },
  {
    "objectID": "slides/index.html#roches-end-to-end-r-journey-to-submission",
    "href": "slides/index.html#roches-end-to-end-r-journey-to-submission",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Roche‚Äôs End-to-End R Journey to Submission",
    "text": "Roche‚Äôs End-to-End R Journey to Submission"
  },
  {
    "objectID": "slides/index.html#section-4",
    "href": "slides/index.html#section-4",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "",
    "text": "From R/Adoption Series: R and Shiny in Regulatory Submissions"
  },
  {
    "objectID": "slides/index.html#section-5",
    "href": "slides/index.html#section-5",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "",
    "text": "From R/Adoption Series: R and Shiny in Regulatory Submissions"
  },
  {
    "objectID": "slides/index.html#section-6",
    "href": "slides/index.html#section-6",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "",
    "text": "From R/Adoption Series: R and Shiny in Regulatory Submissions"
  },
  {
    "objectID": "slides/index.html#section-7",
    "href": "slides/index.html#section-7",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "",
    "text": "Check https://github.com/RConsortium/submissions-pilot2/"
  },
  {
    "objectID": "slides/index.html#findings-and-issues-from-fda",
    "href": "slides/index.html#findings-and-issues-from-fda",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Findings and issues from FDA",
    "text": "Findings and issues from FDA\n \n\nDifferent versions (R and open-source changes fast!)\nDifferent OS (Linux and Windows)\nInteractive features and p-hacking\n\n\n\n1.-2. Docker or WebAssembly (Pilot 4) 3. Even if p-hacking is NOT technology dependent, the ease-of-use and tweaking binds interactive features to the exploratory world\n\n\nFrom Hye Soo Cho, FDA, in R/Adoption Series: R and Shiny in Regulatory Submissions"
  },
  {
    "objectID": "slides/index.html#section-8",
    "href": "slides/index.html#section-8",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "",
    "text": "From R/Adoption Series: R and Shiny in Regulatory Submissions"
  },
  {
    "objectID": "slides/index.html#what-is-nest",
    "href": "slides/index.html#what-is-nest",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "What is NEST",
    "text": "What is NEST\nAccelerating Clinical Reporting\n\n\n\n\nA collection of open-sourced R packages, which enables fast and efficient insights generation under clinical research settings, for both exploratory and regulatory purposes."
  },
  {
    "objectID": "slides/index.html#landscape-of-nest-products",
    "href": "slides/index.html#landscape-of-nest-products",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Landscape of NEST Products",
    "text": "Landscape of NEST Products\nWorking towards a complete solution for R-based insights delivery"
  },
  {
    "objectID": "slides/index.html#preparation",
    "href": "slides/index.html#preparation",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Preparation",
    "text": "Preparation\n\nRecommended: Enter the dedicated RStudio Cloud work space (with packages pre-installed) to complete Exercise 1. It may still be helpful to peek at the exercises web page to verify that your results match the desired output.\n\n‚Üí R in Pharma RStudio Cloud work space ‚Üê\n\nOtherwise: Use your personal computer and follow along the exercises on the website. Challenge yourself not to peek at the code solutions until you have completed the exercise."
  },
  {
    "objectID": "slides/index.html#exercise-1",
    "href": "slides/index.html#exercise-1",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Exercise 1",
    "text": "Exercise 1\n \nCreate a demographic table by using only {dplyr}.\n\n\nThe data should have only age, gender, and treatment columns.\nThe table should include the mean and standard deviation of age, the count and percentage.\n\n\n‚àí+\n10:00"
  },
  {
    "objectID": "slides/index.html#exercise-1---solution",
    "href": "slides/index.html#exercise-1---solution",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Exercise 1 - Solution",
    "text": "Exercise 1 - Solution\n\nCodeOutput\n\n\n# Load necessary libraries\nlibrary(dplyr)\n\n# Sample data frame with demographic data\nset.seed(123)\ndata <- data.frame(\n  id = 1:100,\n  age = sample(18:80, 100, replace = TRUE),\n  gender = sample(c(\"Male\", \"Female\"), 100, replace = TRUE),\n  treatment = sample(c(\"Treatment A\", \"Treatment B\"), 100, replace = TRUE)\n)\n\nhead(data)\n\n\n\n\n\n\n  \n    \n      id\n      age\n      gender\n      treatment\n    \n  \n  \n    1\n48\nFemale\nTreatment B\n    2\n32\nFemale\nTreatment B\n    3\n68\nMale\nTreatment A\n    4\n31\nFemale\nTreatment B\n    5\n20\nFemale\nTreatment B\n    6\n59\nMale\nTreatment B"
  },
  {
    "objectID": "slides/index.html#exercise-1---solution-1",
    "href": "slides/index.html#exercise-1---solution-1",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Exercise 1 - Solution",
    "text": "Exercise 1 - Solution\n\nCodeOutput\n\n\n# Count participants per treatment group to get labels with counts\ntreatment_counts <- data |> \n  count(treatment) |> \n  mutate(treatment_label = paste0(treatment, \" (N=\", n, \")\"))\n\n# Create the demographic summary table\ndemographic_table <- data |> \n  # Join with treatment counts to include the labeled treatment names\n  left_join(treatment_counts, by = \"treatment\") |>\n  # Summarize age, female, and male counts and percentages by the labeled treatment\n  group_by(treatment_label) |> \n  summarise(\n    `Mean Age (SD)` = paste0(round(mean(age), 1), \" (\", round(sd(age), 1), \")\"),\n    `N Female (%)` = paste0(sum(gender == \"Female\"), \" (\", round(sum(gender == \"Female\") / n() * 100, 1), \"%)\"),\n    `N Male (%)` = paste0(sum(gender == \"Male\"), \" (\", round(sum(gender == \"Male\") / n() * 100, 1), \"%)\"),\n    .groups = \"drop\"\n  ) |>\n  # Transpose for easy review if needed\n  t() |>\n  print()\n\n\n\n\n\n\n\n\n\n\n\nTreatment A (N=51)\n\n\nTreatment B (N=49)\n\n\n\n\n\n\n\nMean Age (SD)\n\n\n50.3 (17.9)\n\n\n45.7 (16.3)\n\n\n\n\nN Female (%)\n\n\n27 (52.9%)\n\n\n28 (57.1%)\n\n\n\n\nN Male (%)\n\n\n24 (47.1%)\n\n\n21 (42.9%)"
  },
  {
    "objectID": "slides/index.html#exercise-1---bonus-solution",
    "href": "slides/index.html#exercise-1---bonus-solution",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Exercise 1 - Bonus Solution",
    "text": "Exercise 1 - Bonus Solution\nHere is how to do it in {rtables} (for tabulation) and {tern} (for the summary functions):\nlibrary(rtables)\nlibrary(tern)\n\nlyt <- basic_table() |> \n  split_cols_by(\"treatment\") |> \n  analyze_vars(c(\"gender\", \"age\"))\n\nbuild_table(lyt, data) |> \n  as_html()\n\n\n\n\n\n\n\n\n\n\n\nTreatment B\nTreatment A\n\n\ngender\n\n\n\n\n  n\n49\n51\n\n\n  Female\n28 (57.1%)\n27 (52.9%)\n\n\n  Male\n21 (42.9%)\n24 (47.1%)\n\n\nage\n\n\n\n\n  n\n49\n51\n\n\n  Mean (SD)\n45.7 (16.3)\n50.3 (17.9)\n\n\n  Median\n44.0\n49.0\n\n\n  Min - Max\n20.0 - 79.0\n21.0 - 80.0\n\n\n\n\n\n\nCheck {rtables} documentation"
  },
  {
    "objectID": "slides/index.html#exercise-2",
    "href": "slides/index.html#exercise-2",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Exercise 2",
    "text": "Exercise 2\nBuild the following demographic table using {rtables} or {gtsummary}.\n\n\nFrom FDA Standard Safety Tables and Figures: Integrated Guide"
  },
  {
    "objectID": "slides/index.html#some-useful-resources",
    "href": "slides/index.html#some-useful-resources",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Some useful resources ;)",
    "text": "Some useful resources ;)\n\n\n\n\n\n\n\n\nCheck cardinal"
  },
  {
    "objectID": "slides/index.html#exercise-2---data",
    "href": "slides/index.html#exercise-2---data",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Exercise 2 - Data",
    "text": "Exercise 2 - Data\n\n\n\n\n\n\nData Tip\n\n\nChecking {cardinal} template you can directly use the synthetic data set as described.\n\n\n\n\n::: panel-tabset ### Code\nadsl <- random.cdisc.data::cadsl\nadvs <- random.cdisc.data::cadvs\n\n# Pre-Processing - Add any variables needed in your table to df\nadsl <- adsl |> \n  mutate(AGEGR1 = as.factor(case_when(\n    AGE >= 17 & AGE < 65 ~ \"‚â•17 to &lt;65\",\n    AGE >= 65 ~ \"‚â•65\",\n    AGE >= 65 & AGE < 75 ~ \"‚â•65 to &lt;75\",\n    AGE >= 75 ~ \"‚â•75\"\n  )))\n\nadvs <- advs |> \n  filter(AVISIT == \"BASELINE\", VSTESTCD == \"TEMP\") |>\n  select(\"USUBJID\", \"AVAL\")\n\nanl <- left_join(adsl, advs, by = \"USUBJID\")\n\nhead(anl)\nOutput\n\n\n\n\n  \n    \n      Study Identifier\n      Unique Subject Identifier\n      Subject Identifier for the Study\n      Study Site Identifier\n      Age\n      Age Units\n      Sex\n      Race\n      Ethnicity\n      Country\n      Subject Death Flag\n      Investigator Identifier\n      Investigator Name\n      Description of Planned Arm\n      Planned Arm Code\n      Description of Actual Arm\n      Actual Arm Code\n      Planned Treatment for Period 01\n      Actual Treatment for Period 01\n      Planned Treatment for Period 02\n      Actual Treatment for Period 02\n      Geographic Region 1\n      Stratification Factor 1\n      Stratification Factor 2\n      Continuous Level Biomarker 1\n      Categorical Level Biomarker 2\n      Intent-To-Treat Population Flag\n      Safety Population Flag\n      Response Evaluable Population Flag\n      Biomarker Evaluable Population Flag\n      AE Leading to Drug Withdrawal Flag\n      Date of Randomization\n      Datetime of First Exposure to Treatment\n      Datetime of Last Exposure to Treatment\n      Datetime of First Exposure to Treatment in Period 01\n      Datetime of Last Exposure in Period 01\n      Datetime of First Exposure to Treatment in Period 02\n      Datetime of Last Exposure to Treatment in Period 02\n      Period 01 Start Datetime\n      Period 01 End Datetime\n      Period 02 Start Datetime\n      Period 02 End Datetime\n      End of Study Status\n      End of Treatment Status\n      End of Study Date\n      End of Study Relative Day\n      Reason for Discontinuation from Study\n      Date of Death\n      Cause of Death\n      Cause of Death Category\n      Elapsed Days from Last Dose to Death\n      Last Dose to Death - Days Elapsed Grp 1\n      Date Last Known Alive\n      Relative Day of Death\n      Autopsy Performed\n      AGEGR1\n      Analysis Value\n    \n  \n  \n    AB12345\nAB12345-CHN-3-id-128\nid-128\nCHN-3\n32\nYEARS\nM\nASIAN\nHISPANIC OR LATINO\nCHN\nY\nINV ID CHN-3\nDr. CHN-3 Doe\nA: Drug X\nARM A\nA: Drug X\nARM A\nA: Drug X\nA: Drug X\nB: Placebo\nA: Drug X\nAsia\nC\nS2\n14.424934\nMEDIUM\nY\nY\nY\nY\nN\n2019-02-22\n2019-02-24 11:09:25.683\n2022-02-12 04:28:08.683\n2019-02-24 11:09:25.683\n2021-02-11 22:28:08.683\n2021-02-11 22:28:08.683\n2022-02-12 04:28:08.683\n2019-02-24 11:09:25.683\n2021-02-11 22:28:08.683\n2021-02-11 22:28:08.683\n2022-02-12 04:28:08.683\nDISCONTINUED\nDISCONTINUED\n2022-02-12\n1084\nDEATH\n2022-03-06\nADVERSE EVENT\nADVERSE EVENT\n22\n<=30\n2022-03-06\n1105\nYes\n‚â•17 to &lt;65\n37.21088\n    AB12345\nAB12345-CHN-15-id-262\nid-262\nCHN-15\n35\nYEARS\nM\nBLACK OR AFRICAN AMERICAN\nNOT HISPANIC OR LATINO\nCHN\nN\nINV ID CHN-15\nDr. CHN-15 Doe\nC: Combination\nARM C\nC: Combination\nARM C\nC: Combination\nC: Combination\nB: Placebo\nC: Combination\nAsia\nC\nS1\n4.055463\nLOW\nY\nY\nN\nN\nY\n2019-02-26\n2019-02-26 09:05:10.683\n2022-02-26 03:05:10.683\n2019-02-26 09:05:10.683\n2021-02-25 21:05:10.683\n2021-02-25 21:05:10.683\n2022-02-26 03:05:10.683\n2019-02-26 09:05:10.683\n2021-02-25 21:05:10.683\n2021-02-25 21:05:10.683\n2022-02-26 03:05:10.683\nCOMPLETED\nCOMPLETED\n2022-02-26\n1096\nNA\nNA\nNA\nNA\nNA\nNA\n2022-03-17\nNA\nNA\n‚â•17 to &lt;65\n37.91017\n    AB12345\nAB12345-RUS-3-id-378\nid-378\nRUS-3\n30\nYEARS\nF\nASIAN\nNOT HISPANIC OR LATINO\nRUS\nN\nINV ID RUS-3\nDr. RUS-3 Doe\nC: Combination\nARM C\nC: Combination\nARM C\nC: Combination\nC: Combination\nA: Drug X\nB: Placebo\nEurasia\nA\nS1\n2.803240\nHIGH\nY\nY\nY\nN\nN\n2019-02-24\n2019-02-28 03:19:22.683\n2022-02-27 21:19:22.683\n2019-02-28 03:19:22.683\n2021-02-27 15:19:22.683\n2021-02-27 15:19:22.683\n2022-02-27 21:19:22.683\n2019-02-28 03:19:22.683\n2021-02-27 15:19:22.683\n2021-02-27 15:19:22.683\n2022-02-27 21:19:22.683\nCOMPLETED\nCOMPLETED\n2022-02-27\n1096\nNA\nNA\nNA\nNA\nNA\nNA\n2022-03-11\nNA\nNA\n‚â•17 to &lt;65\n35.53659\n    AB12345\nAB12345-CHN-11-id-220\nid-220\nCHN-11\n26\nYEARS\nF\nASIAN\nNOT HISPANIC OR LATINO\nCHN\nN\nINV ID CHN-11\nDr. CHN-11 Doe\nB: Placebo\nARM B\nB: Placebo\nARM B\nB: Placebo\nB: Placebo\nB: Placebo\nB: Placebo\nAsia\nB\nS2\n10.262734\nMEDIUM\nY\nY\nY\nY\nN\n2019-02-27\n2019-03-01 13:33:19.683\n2022-03-01 07:33:19.683\n2019-03-01 13:33:19.683\n2021-03-01 01:33:19.683\n2021-03-01 01:33:19.683\n2022-03-01 07:33:19.683\n2019-03-01 13:33:19.683\n2021-03-01 01:33:19.683\n2021-03-01 01:33:19.683\n2022-03-01 07:33:19.683\nCOMPLETED\nCOMPLETED\n2022-03-01\n1096\nNA\nNA\nNA\nNA\nNA\nNA\n2022-03-26\nNA\nNA\n‚â•17 to &lt;65\n37.75094\n    AB12345\nAB12345-CHN-7-id-267\nid-267\nCHN-7\n40\nYEARS\nM\nASIAN\nNOT HISPANIC OR LATINO\nCHN\nN\nINV ID CHN-7\nDr. CHN-7 Doe\nB: Placebo\nARM B\nB: Placebo\nARM B\nB: Placebo\nB: Placebo\nC: Combination\nA: Drug X\nAsia\nC\nS1\n6.206763\nLOW\nY\nY\nN\nN\nN\n2019-03-01\n2019-03-02 00:09:33.683\n2022-03-01 18:09:33.683\n2019-03-02 00:09:33.683\n2021-03-01 12:09:33.683\n2021-03-01 12:09:33.683\n2022-03-01 18:09:33.683\n2019-03-02 00:09:33.683\n2021-03-01 12:09:33.683\n2021-03-01 12:09:33.683\n2022-03-01 18:09:33.683\nCOMPLETED\nCOMPLETED\n2022-03-01\n1096\nNA\nNA\nNA\nNA\nNA\nNA\n2022-03-15\nNA\nNA\n‚â•17 to &lt;65\n33.65185\n    AB12345\nAB12345-CHN-15-id-201\nid-201\nCHN-15\n49\nYEARS\nM\nASIAN\nNOT HISPANIC OR LATINO\nCHN\nY\nINV ID CHN-15\nDr. CHN-15 Doe\nC: Combination\nARM C\nC: Combination\nARM C\nC: Combination\nC: Combination\nB: Placebo\nC: Combination\nAsia\nC\nS2\n6.906799\nMEDIUM\nY\nY\nY\nN\nN\n2019-03-05\n2019-03-05 15:24:07.683\n2022-02-19 04:06:48.683\n2019-03-05 15:24:07.683\n2021-02-18 22:06:48.683\n2021-02-18 22:06:48.683\n2022-02-19 04:06:48.683\n2019-03-05 15:24:07.683\n2021-02-18 22:06:48.683\n2021-02-18 22:06:48.683\n2022-02-19 04:06:48.683\nDISCONTINUED\nDISCONTINUED\n2022-02-19\n1082\nDEATH\n2022-02-22\nADVERSE EVENT\nADVERSE EVENT\n3\n<=30\n2022-02-22\n1084\nYes\n‚â•17 to &lt;65\n36.49592"
  },
  {
    "objectID": "slides/index.html#exercise-2---building-the-table",
    "href": "slides/index.html#exercise-2---building-the-table",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Exercise 2 - Building the table",
    "text": "Exercise 2 - Building the table\n\n\n\n\n\n\nTip\n\n\nCheck the function make_table_02 or make_table_02_gtsum from {cardinal} here\n\n\n\n\n‚àí+\n15:00"
  },
  {
    "objectID": "slides/index.html#exercise-2---rtables-solution",
    "href": "slides/index.html#exercise-2---rtables-solution",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Exercise 2 - {rtables} solution",
    "text": "Exercise 2 - {rtables} solution\n\nCodeOutput\n\n\ndf <- anl |>\n  df_explicit_na()\n\nvars <- c(\"SEX\", \"AGE\", \"AGEGR1\", \"RACE\", \"ETHNIC\", \"COUNTRY\")\nlbl_vars <- formatters::var_labels(df, fill = TRUE)[vars]\n\nlyt <- basic_table(show_colcounts = TRUE) |>\n  split_cols_by(\"ARM\", split_fun = add_overall_level(\"Total Population\", first = FALSE)) |>\n  analyze_vars(\n    vars = vars,\n    var_labels = lbl_vars,\n    show_labels = \"visible\",\n    .stats = c(\"mean_sd\", \"median_range\", \"count_fraction\"),\n    .formats = NULL,\n    na.rm = FALSE\n  ) |>\n  append_topleft(\"Characteristic\")\n\ntbl <- build_table(lyt, df = df) |> \n  prune_table()\n\ntbl\n\n\n\n\n\n\n\n\n\n\n\n\n\nA: Drug X\nB: Placebo\nC: Combination\nTotal Population\n\n\nCharacteristic\n(N=134)\n(N=134)\n(N=132)\n(N=400)\n\n\nSex\n\n\n\n\n\n\n  F\n79 (59%)\n82 (61.2%)\n70 (53%)\n231 (57.8%)\n\n\n  M\n55 (41%)\n52 (38.8%)\n62 (47%)\n169 (42.2%)\n\n\nAge\n\n\n\n\n\n\n  Mean (SD)\n33.8 (6.6)\n35.4 (7.9)\n35.4 (7.7)\n34.9 (7.4)\n\n\n  Median (Min - Max)\n33.0 (21.0 - 50.0)\n35.0 (21.0 - 62.0)\n35.0 (20.0 - 69.0)\n34.0 (20.0 - 69.0)\n\n\nAGEGR1\n\n\n\n\n\n\n  ‚â•17 to &lt;65\n134 (100%)\n134 (100%)\n131 (99.2%)\n399 (99.8%)\n\n\n  ‚â•65\n0\n0\n1 (0.8%)\n1 (0.2%)\n\n\nRace\n\n\n\n\n\n\n  ASIAN\n68 (50.7%)\n67 (50%)\n73 (55.3%)\n208 (52%)\n\n\n  BLACK OR AFRICAN AMERICAN\n31 (23.1%)\n28 (20.9%)\n32 (24.2%)\n91 (22.8%)\n\n\n  WHITE\n27 (20.1%)\n26 (19.4%)\n21 (15.9%)\n74 (18.5%)\n\n\n  AMERICAN INDIAN OR ALASKA NATIVE\n8 (6%)\n11 (8.2%)\n6 (4.5%)\n25 (6.2%)\n\n\n  MULTIPLE\n0\n1 (0.7%)\n0\n1 (0.2%)\n\n\n  NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER\n0\n1 (0.7%)\n0\n1 (0.2%)\n\n\nEthnicity\n\n\n\n\n\n\n  HISPANIC OR LATINO\n15 (11.2%)\n18 (13.4%)\n15 (11.4%)\n48 (12%)\n\n\n  NOT HISPANIC OR LATINO\n104 (77.6%)\n103 (76.9%)\n101 (76.5%)\n308 (77%)\n\n\n  NOT REPORTED\n6 (4.5%)\n10 (7.5%)\n11 (8.3%)\n27 (6.8%)\n\n\n  UNKNOWN\n9 (6.7%)\n3 (2.2%)\n5 (3.8%)\n17 (4.2%)\n\n\nCountry\n\n\n\n\n\n\n  CHN\n74 (55.2%)\n81 (60.4%)\n64 (48.5%)\n219 (54.8%)\n\n\n  USA\n10 (7.5%)\n13 (9.7%)\n17 (12.9%)\n40 (10%)\n\n\n  BRA\n13 (9.7%)\n7 (5.2%)\n10 (7.6%)\n30 (7.5%)\n\n\n  PAK\n12 (9%)\n9 (6.7%)\n10 (7.6%)\n31 (7.8%)\n\n\n  NGA\n8 (6%)\n7 (5.2%)\n11 (8.3%)\n26 (6.5%)\n\n\n  RUS\n5 (3.7%)\n8 (6%)\n6 (4.5%)\n19 (4.8%)\n\n\n  JPN\n5 (3.7%)\n4 (3%)\n9 (6.8%)\n18 (4.5%)\n\n\n  GBR\n4 (3%)\n3 (2.2%)\n2 (1.5%)\n9 (2.2%)\n\n\n  CAN\n3 (2.2%)\n2 (1.5%)\n3 (2.3%)\n8 (2%)"
  },
  {
    "objectID": "slides/index.html#exercise-2---gtsummary-solution",
    "href": "slides/index.html#exercise-2---gtsummary-solution",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Exercise 2 - {gtsummary} solution",
    "text": "Exercise 2 - {gtsummary} solution\n\nCodeOutput\n\n\nlibrary(gtsummary)\n\ndf <- df |> df_explicit_na()\nvars <- c(\"SEX\", \"AGE\", \"AGEGR1\", \"RACE\", \"ETHNIC\", \"COUNTRY\")\nlbl_vars <- formatters::var_labels(df, fill = TRUE)[vars]\n\ntbl <- df  |> \n  select(c(vars, \"ARM\")) |> \n  tbl_summary(\n    by = \"ARM\",\n    type = all_continuous() ~ \"continuous2\",\n    statistic = list(\n      all_continuous() ~ c(\n        \"{mean} ({sd})\",\n        \"{median} ({min} - {max})\"\n      ),\n      all_categorical() ~ \"{n} ({p}%)\"\n    ),\n    digits = all_continuous() ~ 1,\n    missing = \"ifany\",\n    label = as.list(lbl_vars) |> setNames(vars)\n  ) |>\n  gtsummary::bold_labels() |>\n  modify_header(all_stat_cols() ~ \"**{level}**  \\nN = {n}\") |>\n  add_overall(last = TRUE, col_label = paste0(\"**\", \"Total Population\", \"**  \\nN = {n}\")) |>\n  gtsummary::add_stat_label(label = all_continuous2() ~ c(\"Mean (SD)\", \"Median (min - max)\")) |>\n  modify_footnote(update = everything() ~ NA) |>\n  gtsummary::modify_column_alignment(columns = all_stat_cols(), align = \"right\")\n\ntbl\n\n\n\n\n\n\n  \n    \n      Characteristic\n      A: Drug X\nN = 134\n      B: Placebo\nN = 134\n      C: Combination\nN = 132\n      Total Population\nN = 400\n    \n  \n  \n    Sex, n (%)\n\n\n\n\n    ¬†¬†¬†¬†F\n79 (59%)\n82 (61%)\n70 (53%)\n231 (58%)\n    ¬†¬†¬†¬†M\n55 (41%)\n52 (39%)\n62 (47%)\n169 (42%)\n    Age\n\n\n\n\n    ¬†¬†¬†¬†Mean (SD)\n33.8 (6.6)\n35.4 (7.9)\n35.4 (7.7)\n34.9 (7.4)\n    ¬†¬†¬†¬†Median (min - max)\n33.0 (21.0 - 50.0)\n35.0 (21.0 - 62.0)\n35.0 (20.0 - 69.0)\n34.0 (20.0 - 69.0)\n    AGEGR1, n (%)\n\n\n\n\n    ¬†¬†¬†¬†‚â•17 to &lt;65\n134 (100%)\n134 (100%)\n131 (99%)\n399 (100%)\n    ¬†¬†¬†¬†‚â•65\n0 (0%)\n0 (0%)\n1 (0.8%)\n1 (0.3%)\n    Race, n (%)\n\n\n\n\n    ¬†¬†¬†¬†ASIAN\n68 (51%)\n67 (50%)\n73 (55%)\n208 (52%)\n    ¬†¬†¬†¬†BLACK OR AFRICAN AMERICAN\n31 (23%)\n28 (21%)\n32 (24%)\n91 (23%)\n    ¬†¬†¬†¬†WHITE\n27 (20%)\n26 (19%)\n21 (16%)\n74 (19%)\n    ¬†¬†¬†¬†AMERICAN INDIAN OR ALASKA NATIVE\n8 (6.0%)\n11 (8.2%)\n6 (4.5%)\n25 (6.3%)\n    ¬†¬†¬†¬†MULTIPLE\n0 (0%)\n1 (0.7%)\n0 (0%)\n1 (0.3%)\n    ¬†¬†¬†¬†NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER\n0 (0%)\n1 (0.7%)\n0 (0%)\n1 (0.3%)\n    ¬†¬†¬†¬†OTHER\n0 (0%)\n0 (0%)\n0 (0%)\n0 (0%)\n    ¬†¬†¬†¬†UNKNOWN\n0 (0%)\n0 (0%)\n0 (0%)\n0 (0%)\n    Ethnicity, n (%)\n\n\n\n\n    ¬†¬†¬†¬†HISPANIC OR LATINO\n15 (11%)\n18 (13%)\n15 (11%)\n48 (12%)\n    ¬†¬†¬†¬†NOT HISPANIC OR LATINO\n104 (78%)\n103 (77%)\n101 (77%)\n308 (77%)\n    ¬†¬†¬†¬†NOT REPORTED\n6 (4.5%)\n10 (7.5%)\n11 (8.3%)\n27 (6.8%)\n    ¬†¬†¬†¬†UNKNOWN\n9 (6.7%)\n3 (2.2%)\n5 (3.8%)\n17 (4.3%)\n    Country, n (%)\n\n\n\n\n    ¬†¬†¬†¬†CHN\n74 (55%)\n81 (60%)\n64 (48%)\n219 (55%)\n    ¬†¬†¬†¬†USA\n10 (7.5%)\n13 (9.7%)\n17 (13%)\n40 (10%)\n    ¬†¬†¬†¬†BRA\n13 (9.7%)\n7 (5.2%)\n10 (7.6%)\n30 (7.5%)\n    ¬†¬†¬†¬†PAK\n12 (9.0%)\n9 (6.7%)\n10 (7.6%)\n31 (7.8%)\n    ¬†¬†¬†¬†NGA\n8 (6.0%)\n7 (5.2%)\n11 (8.3%)\n26 (6.5%)\n    ¬†¬†¬†¬†RUS\n5 (3.7%)\n8 (6.0%)\n6 (4.5%)\n19 (4.8%)\n    ¬†¬†¬†¬†JPN\n5 (3.7%)\n4 (3.0%)\n9 (6.8%)\n18 (4.5%)\n    ¬†¬†¬†¬†GBR\n4 (3.0%)\n3 (2.2%)\n2 (1.5%)\n9 (2.3%)\n    ¬†¬†¬†¬†CAN\n3 (2.2%)\n2 (1.5%)\n3 (2.3%)\n8 (2.0%)\n    ¬†¬†¬†¬†CHE\n0 (0%)\n0 (0%)\n0 (0%)\n0 (0%)"
  },
  {
    "objectID": "slides/index.html#exercise-3---tlg-catalog",
    "href": "slides/index.html#exercise-3---tlg-catalog",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Exercise 3 - TLG-catalog",
    "text": "Exercise 3 - TLG-catalog\n\n \nLets try now to build an ANCOVA efficacy table with a single visit and single endpoint.\n\n\n\n\n\n\n\n\n\nTip\n\n\n\nPeak at solution AOVT02 on the TLG-catalog and try to understand each function!!\n\n\n\n\n\n‚àí+\n10:00\n\n\nCheck TLG-catalog for hundreds of ready-made TLGs"
  },
  {
    "objectID": "slides/index.html#exercise-3-bonus---teal",
    "href": "slides/index.html#exercise-3-bonus---teal",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Exercise 3 Bonus - {teal}",
    "text": "Exercise 3 Bonus - {teal}\n\n \nLets try now to use the above table to build a {teal} interactive table!\n\n\n\n\n\n\n\n\n\nTip\n\n\n\nPeak at solution AOVT02 for teal too! and try to understand each function!!\n\n\n\n\n\n‚àí+\n10:00\n\n\nCheck TLG-catalog for hundreds of ready-made TLGs"
  },
  {
    "objectID": "slides/index.html#exercise-3-bonus---teal-1",
    "href": "slides/index.html#exercise-3-bonus---teal-1",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Exercise 3 Bonus - {teal}",
    "text": "Exercise 3 Bonus - {teal}\n \nTry to use the data from before (Exercise 1) to make your own teal app (tip: use tm_t_summary)."
  },
  {
    "objectID": "slides/index.html#exercise-4---kaplan-meier-plot",
    "href": "slides/index.html#exercise-4---kaplan-meier-plot",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Exercise 4 - Kaplan-Meier plot",
    "text": "Exercise 4 - Kaplan-Meier plot\n\n \nLets try now to create an efficacy Kaplan-Meier plot. \n\n\n\n\n\n\n\n\nTip\n\n\n\nPeak at solution KMG01 and try to understand each function!!\n\n\n\n\n\n‚àí+\n10:00\n\n\nCheck TLG-catalog for hundreds of ready-made TLGs"
  },
  {
    "objectID": "slides/index.html#exercise-5---try-teal.gallery",
    "href": "slides/index.html#exercise-5---try-teal.gallery",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Exercise 5 - Try {teal.gallery}",
    "text": "Exercise 5 - Try {teal.gallery}\n\n\n\n\n\n\nPlay with efficacy app ;)\n\n\n\nteal.gallery"
  },
  {
    "objectID": "slides/index.html#additional-resources",
    "href": "slides/index.html#additional-resources",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Additional resources",
    "text": "Additional resources\nWhere to find more on NEST\n\n\n\nSource code of all our packages:  https://github.com/insightsengineering\n\n\n\n\n\nNEST is part of https://pharmaverse.org/"
  },
  {
    "objectID": "slides/index.html#additional-resources-1",
    "href": "slides/index.html#additional-resources-1",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Additional resources",
    "text": "Additional resources\nWhere to find more on NEST\n\n\n\nHands On Clinical Reporting Using R | Coursera"
  },
  {
    "objectID": "slides/index.html#collaborate",
    "href": "slides/index.html#collaborate",
    "title": "The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity",
    "section": "Collaborate",
    "text": "Collaborate\nHow can I get involved?\n\n  \nNotice a üêõ or an idea for enhancementsüí°?"
  },
  {
    "objectID": "slidespage.html",
    "href": "slidespage.html",
    "title": "Slides",
    "section": "",
    "text": "View slides in full screen"
  }
]